Novartis targets primary care business in US commercial overhaul
This article was originally published in Scrip
Executive Summary
Novartis is to restructure its US sales operations by streamlining its primary care business and increasing its presence in specialty areas. The changes include wide-reaching consolidation and the loss of nearly 400 positions to support the new commercial model deployed last year.